- Global Pharma News & Resources

Exclusive interview with Dr Eric Noehrenberg, President, NIPC released ahead of Parallel Trade conference 2021

SMi Reports: SMi Group are delighted to announce that Dr Eric Noehrenberg, President, NIPC will be a speaker at the Parallel Trade virtual conference taking place in March 2021.

SMi Group is delighted to present the 15th annual conference which is virtual on the 22nd – 23rd March 2021. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

Event brochure and complete speaker line-up is available on the website here:

In the run up to the conference, Dr Eric Noehrenberg is interviewed by SMi Group to discuss his thoughts on Brexit and UK will no longer be part of the EU free market.

Snapshot of Eric’s interview:

What kind of impact do you think a no deal Brexit will have on the field of Parallel Trade following the end of the transition period?

“A “no-deal Brexit” will certainly make parallel trading between the EU and the EEA more difficult, as goods placed on the UK market by, or with the consent of, the right holder after the transition period will no longer be considered exhausted in the EEA. This means that businesses exporting these IP-protected goods from the UK to the EEA will need the right holder’s consent. Likewise, goods imported from the EEA into the UK will also need the permission of the rights-holder in the UK before importation can legally take place. In my view, this will lead to better quality of supply and greater safety among UK consumers.”

What are your thoughts on how COVID-19 is currently impacting the Parallel Trade industry and your role?

“Once again, an international health care crisis illustrates the dangers to consumers posed by parallel trade and resulting drug shortages. That is why governments have taken strong action to protect their countries’ respective drug supplies during the COVID-19 pandemic crisis. A case in point arose in March 2020 in the UK, where the UK Department of Health and Social Care (DHSC) has banned 80 "crucial" medicines which are in high demand across Europe from parallel export, to ensure a consistent supply for UK patients who need them.”

Download the full interview:

Proudly sponsored by UL Global Pharma & Alira Health

--- ENDS ---

Contact Information:

For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email:

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

Exclusive interview with Dr Eric Noehrenberg, President, NIPC released ahead of Parallel Trade conference 2021

Editor Details

Related Links

Last Updated: 08-Dec-2020